Pembrolizumab Injection 100 mg
Pembrolizumab Injection is used in: Patients whose cancer cannot be removed by surgery or has metastasized (spread to other parts of the body).
Rituximab Injection 100 mg
Rituximab injection is used alone or together with other medicines to treat a type of cancer called non-Hodgkin’s lymphoma (NHL). It is also used in combination with other cancer medicines to treat mature B-cell non-Hodgkin’s lymphoma (NHL) and mature B-cell acute leukemia (B-AL).
Brentuximab Vedotin Injection 50 mg
Brentuximab Vedotin Injection is used to treat a certain type of primary cutaneous anaplastic large cell lymphoma (pcALCL; a type of non-Hodgkin’s lymphoma) in people who have previously received another treatment.
Blinatumomab Injection 38.5 mcg
Blinatumomab Injection is used in adults and children to treat certain types of acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells) that has not gotten better, or that has returned after treatment with other medications.
Fedratinib Capsules 100 mg
Fedratinib Capsules is used to treat myelofibrosis in adults. Myelofibrosis is a rare type of bone marrow cancer that affects your body’s ability to produce blood cells.